UnitedHealth Price Target Raised to $337 by BofA After Medicare Advantage Rate Finalization

Bank of America raised its UnitedHealth (UNH) price target to $337 from $315 — a $22 increase, roughly +7.0% — following a key Medicare Advantage policy update, signaling increased analyst confidence in UNH's MA exposure. The upgrade is a modest positive for the stock and reflects supportive regulatory developments, but is likely a firm-specific catalyst rather than a market-moving event.

Analysis

Bank of America raised its UnitedHealth (UNH) price target to $337 from $315 — a $22 increase, roughly +7.0% — following a key Medicare Advantage policy update, signaling increased analyst confidence in UNH's MA exposure. The upgrade is a modest positive for the stock and reflects supportive regulatory developments, but is likely a firm-specific catalyst rather than a market-moving event.